Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRTP-103
- Development stage
- Preclinical
- Lead developer
- CellinCells
- Modality
- Cell Therapies
- Administration
- Subcutaneous, Topical
01
Overview
TRTP-103 is an investigational organelle-based therapeutic candidate being developed by Cell In Cells, a South Korean biotechnology company. It utilizes the company's proprietary "Cell-to-Cell Transfer" (C2C) technology to deliver healthy, functional mitochondria into target cells. The therapy is specifically designed to treat hair loss (alopecia) by addressing mitochondrial dysfunction in hair follicle cells, which is a significant factor in cellular aging and follicle miniaturization. By replenishing functional mitochondria and restoring cellular energy metabolism (ATP production), TRTP-103 aims to revitalize hair follicles and promote hair regeneration and growth.
Beyond the preview
Go deeper on TRTP-103.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRTP-103.